Thompson Joseph P, Bennett Davinia, Hodson James, Asia Miriam, Ayuk John, O'Reilly Michael W, Karavitaki Niki, Arlt Wiebke, Sutcliffe Robert P
HPB Surgery Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Anaesthetic Department, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Gland Surg. 2019 Dec;8(6):729-739. doi: 10.21037/gs.2019.11.22.
Due to risk of haemodynamic instability (HDI), it has been recommended that patients undergoing adrenalectomy for phaeochromocytoma should be monitored in an intensive care facility. The aim of this study was to evaluate the incidence, risk factors and outcomes of postoperative HDI in these patients. Retrospective cohort study of 46 consecutive patients who underwent open (OA, N=26) or laparoscopic (LA, N=20) adrenalectomy for phaeochromocytoma at a single centre [2007-2017].
HDI was defined as systolic BP >200 or <90 mmHg, heart rate >120 or <50 bpm or vasopressor therapy within 24 hours. Risk factors for intraoperative and postoperative HDI were evaluated by univariable and multivariable analyses.
Intraoperative hypertension occurred in 25/42 patients (60%). Preoperative plasma normetanephrine levels ≥3,500 pmol/L were significantly associated with intraoperative hypertension on multivariable analysis [odds ratio (OR) 42; 95% CI: 4-429; P=0.002). Postoperative hypotension occurred in 21/45 patients (47%), and 13 (29%) required vasopressor therapy. Preoperative beta-blockade therapy was the only independent risk factor for postoperative hypotension on multivariable analysis (OR 4.0; 95% CI: 1.2-13.9, P=0.029). No patients (0/9) with tumours <5 cm treated by LA needed postoperative vasopressor therapy, compared to 39% (7/18) treated by OA (P=0.059). Complications developed in 9 patients (20%), and were less likely in those with intraoperative hypertension (8% . 41%; P=0.019). There was one postoperative death.
Preoperative beta-blockade therapy is an independent risk factor for postoperative HDI after adrenalectomy for phaeochromocytoma. Patients who undergo laparoscopic adrenalectomy (LA) for phaeochromocytomas <5 cm are unlikely to need postoperative vasopressor therapy, and may not require intensive care monitoring.
由于存在血流动力学不稳定(HDI)风险,建议对因嗜铬细胞瘤接受肾上腺切除术的患者在重症监护病房进行监测。本研究的目的是评估这些患者术后HDI的发生率、危险因素和结局。对2007年至2017年在单一中心连续接受开放性(OA,N = 26)或腹腔镜(LA,N = 20)肾上腺切除术治疗嗜铬细胞瘤的46例患者进行回顾性队列研究。
HDI定义为收缩压>200或<90 mmHg、心率>120或<50次/分钟或在24小时内接受血管升压药治疗。通过单变量和多变量分析评估术中及术后HDI的危险因素。
42例患者中有25例(60%)发生术中高血压。多变量分析显示,术前血浆去甲变肾上腺素水平≥3500 pmol/L与术中高血压显著相关[比值比(OR)42;95%置信区间:4 - 429;P = 0.002]。45例患者中有21例(47%)发生术后低血压,13例(29%)需要血管升压药治疗。多变量分析显示,术前β受体阻滞剂治疗是术后低血压的唯一独立危险因素(OR 4.0;95%置信区间:1.2 - 13.9,P = 0.029)。与接受OA治疗的39%(7/18)患者相比,接受LA治疗的肿瘤<5 cm的患者中无一例(0/9)需要术后血管升压药治疗(P = 0.059)。9例患者(20%)出现并发症,术中高血压患者出现并发症的可能性较小(8%对41%;P = 0.019)。有1例术后死亡。
术前β受体阻滞剂治疗是嗜铬细胞瘤肾上腺切除术后术后HDI的独立危险因素。接受LA治疗<5 cm嗜铬细胞瘤的患者不太可能需要术后血管升压药治疗,可能不需要重症监护监测。